HbA 1c in pulmonary arterial hypertension: A marker of prognostic relevance?

Journal of Heart and Lung Transplantation

Volumn 31, Issue 10, 2012, Pages 1109-1114

  Belly, Michael J ^a   Tiede, Henning ^a   Morty, Rory E ^a   Schulz, Richard ^a   Voswinckel, Robert ^a,b,c   Tanislav, Christian ^d   Olschewski, Horst ^e   Ghofrani, Hossein A ^a,c   Seeger, Werner ^a,b   Reichenberger, Frank ^a,f  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c Kerckhoff Center   (Germany)

^d UNIVERSITY HOSPITAL GIESSEN   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

Author keywords

diabetes mellitus; glucose metabolism disorder; glycosylated hemoglobin A 1c; impaired glucose metabolism; insulin resistance; pulmonary arterial hypertension

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; STEROID; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONGENITAL HEART MALFORMATION; DEMOGRAPHY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INDEX; HUMAN; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR DISEASE; WALKING; AGED; BLOOD; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 84866078065     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.08.014     Document Type: Article

References (23)

1. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) European Respiratory Society (ERS) International Society of Heart and Lung Transplantation (ISHLT) Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 2009 1219 1263
2. R.M. Tudor, A.L. Zaiman Pathology of pulmonary vascular disease A.J. Peacock, L.J. Rubin, Pulmonary circulation. diseases and their treatment Part 2: Pathophysiology and pathology of pulmonary vascular disease 2004 Arnold London 25 32
3. R. Wensel, C.F. Opitz, S.D. Anker Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing Circulation 106 2002 319 324
4. R.L. Benza, D.P. Miller, M. Gomberg-Maitland Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 164 172
5. P.R. Forfia, S.C. Mathai, M.R. Fisher Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension Am J Respir Crit Care Med 177 2008 1364 1369
6. M.M. Hoeper, M.W. Pletz, H. Golpon Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Eur Respir J 29 2007 944 950
7. G.M. Reaven Banting lecture 1988 Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
8. T. McLaughlin, G. Allison, F. Abbasi Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals Metabolism 53 2004 495 499
9. R. Galetto, M. Albajar, J.I. Polanco Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region Biochem J 357 2001 521 527
10. G. Hansmann, V.A. de Jesus Perez, T.P. Alastalo An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension J Clin Invest 118 2008 1846 1857
11. G. Hansmann, R.A. Wagner, S. Schellong Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation Circulation 115 2007 1275 1284
12. R.T. Zamanian, G. Hansmann, S. Snook Insulin resistance in pulmonary arterial hypertension Eur Respir J 33 2009 318 324
13. M.E. Pugh, I.M. Robbins, T.W. Rice Unrecognized glucose intolerance is common in pulmonary arterial hypertension J Heart Lung Transplant 30 2011 904 911
14. M. Jauss, E. Zanette Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography Cerebrovasc Dis 10 2000 490 496
15. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 suppl 1 2010 S62 S69
16. L.N. Pani, L. Korenda, J.B. Meigs Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004 Diabetes Care 31 2008 1991 1996
17. W. Doehner, M. Rauchhaus, P. Ponikowski Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure J Am Coll Cardiol 46 2005 1019 1026
18. J.W. Swan, S.D. Anker, C. Walton Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
19. S. Rafeq, A.M. Shah, I.R. Preston Biomarkers in pulmonary arterial hypertension Int J Clin Pract Suppl 162 2009 36 41
20. D. Suratwala, J.S. Chan, A. Kelly Nocturnal saturation and glucose tolerance in children with cystic fibrosis Thorax 66 2011 574 578
21. S. Ogawa, K. Takeuchi, S. Ito Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone J Clin Endocrinol Metab 88 2003 3993 3996
22. I.C. van der Horst, R.A. de Boer, H.L. Hillege Neurohormonal profile of patients with heart failure and diabetes Neth Heart J 18 2010 190 196
23. M. Humbert, O. Sitbon, A. Yaici Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Eur Respir J 36 2010 549 555